We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
HCI Group
HCI
$2.29B
| $2.42M | 0.01% |
45,242
+33,457
| +284% | +$1.68M |
|
|
DCBO
1327
Docebo
DCBO
$533M
| $2.42M | 0.01% |
+59,371
| New | +$2.18M |
|
1328
Stagwell
STGW
$1.98B
| $2.42M | 0.01% |
+325,702
| New | +$2.28M |
|
1329
Southwest Gas
SWX
$6.7B
| $2.42M | 0.01% |
38,693
+1,605
| +4% | +$102K |
|
1330
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $2.41M | 0.01% |
32,204
+17,582
| +120% | +$1.26M |
|
1331
Amphastar Pharmaceuticals
AMPH
$888M
| $2.41M | 0.01% |
+64,209
| New | +$2.1M |
|
1332
Coca-Cola Femsa
KOF
$22.8B
| $2.4M | 0.01% |
29,860
-40,006
| -57% | -$2.94M |
|
1333
BorgWarner
BWA
$13B
| $2.4M | 0.01% |
55,571
-74,390
| -57% | -$3.08M |
|
1334
Sabre
SABR
$743M
| $2.4M | 0.01% |
559,152
+284,840
| +104% | +$1.63M |
|
|
CITEW
1335
CALL
DELISTED
Cartica Acquisition Corp Warrant
CITEW
| $2.4M | 0.01% |
227,414
| – | – |
|
1336
Euronet Worldwide
EEFT
$3.15B
| $2.4M | 0.01% |
+21,405
| New | +$2.32M |
|
1337
OneSpaWorld
OSW
$2.82B
| $2.39M | 0.01% |
199,311
+82,171
| +70% | +$895K |
|
1338
CrowdStrike
CRWD
$185B
| $2.39M | 0.01% |
69,628
-94,000
| -57% | -$2.72M |
|
1339
CALL
Oracle
ORCL
$346B
| $2.38M | 0.01% |
25,600
-53,200
| -68% | -$4.67M |
|
1340
B&G Foods
BGS
$297M
| $2.38M | 0.01% |
153,113
-560,746
| -79% | -$7.81M |
|
1341
CALL
US Bancorp
USB
$100B
| $2.37M | 0.01% |
65,800
-113,000
| -63% | -$5.03M |
|
|
RADI
1342
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $2.37M | 0.01% |
161,300
+142,970
| +780% | +$1.94M |
|
1343
iShares Biotechnology ETF
IBB
$9.55B
| $2.36M | 0.01% |
18,287
-60,294
| -77% | -$7.89M |
|
1344
Wynn Resorts
WYNN
$10.3B
| $2.35M | 0.01% |
21,034
+14,179
| +207% | +$1.48M |
|
1345
Ultrapar
UGP
$6.74B
| $2.35M | 0.01% |
861,244
-722,016
| -46% | -$1.82M |
|
1346
M/I Homes
MHO
$3.89B
| $2.35M | 0.01% |
37,194
+15,165
| +69% | +$874K |
|
|
SEMR
1347
DELISTED
Semrush
SEMR
| $2.35M | 0.01% |
233,486
+135,303
| +138% | +$1.19M |
|
|
UTAAW
1348
CALL
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
| $2.34M | 0.01% |
224,999
| – | – |
|
1349
First Trust Cloud Computing ETF
SKYY
$2.82B
| $2.33M | 0.01% |
34,854
-19,751
| -36% | -$1.24M |
|
1350
CALL
iShares MSCI Brazil ETF
EWZ
$9.13B
| $2.33M | 0.01% |
85,100
-543,000
| -86% | -$15.2M |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.